drugset / Trial / NCT00560300
Regulation of Bone Formation in Renal Osteodystrophy
Phase 2
Completed
61 enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
RandomizedFactorialOpen-labelTreatment
Summary
To examine the effects of two types of active vitamin D (calcitriol and doxercalciferol) and two phosphate binders (sevelamer and calcium carbonate) on the bone disease and blood tests of children with kidney failure
Timeline
- Start
- 2000-11
- Primary completion
- —
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | — | — |
| Subject | Calcium carbonate | Other / unclassified | — | — |
| Subject | Doxercalciferol | Small molecule | — | — |
| Subject | Sevelamer | Other / unclassified | — | — |